Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037654920> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W3037654920 endingPage "1180" @default.
- W3037654920 startingPage "1180" @default.
- W3037654920 abstract "Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder chronic in nature and characterized predominantly by abdominal pain or discomfort associated with altered bowel habits, diagnosis requires characteristic symptoms during the last 3 months and onset ≥6 months ago. Symptom-based approaches for functional bloating, constipation and diarrhea are best utilised to identify IBS. IBS with constipation exerts significant impairment on work productivity by hampering quality of life. Inadequate relief by existing modalities, persistent hard stools and visceral abdominal pain demanded further clinical research. Tenanapor a novel molecule acts locally on gastrointestinal sodium/hydrogen exchanger isoform 3 (NHE3), an antiporter a counter transporter and exert antinociceptive effects on visceral sensation thereby decreases the frequency of abdominal pain. Action on NHE3 receptors located on small intestine and colon’s apical surface reduces the absorption of sodium and phosphate, with minimal systemic exposure. NHE3 Inhibition induced sodium absorption results in increase in water secretion into intestinal lumen resultant an accelerated intestinal transit time and softer stool consistency. Most common adverse reactions (≥2%) are diarrhea, abdominal distension, flatulence and dizziness. The drug is metabolised mainly by CYP3A4/5 and excreted in feaces (70%) and urine (7%). Tenapanor’s minimal systemic absorption is likely to be associated with a relatively inert safety and tolerability profile. Based on positive results from the phase III T3MPO trial program, tenapanor demonstrated promising results for IBS-C management and received US Food and Drug Administration approval as IBSRELA @ Ardelyx Pharma in September 2019 and augment existing modalities for management of IBS-C." @default.
- W3037654920 created "2020-07-02" @default.
- W3037654920 creator A5009987567 @default.
- W3037654920 creator A5029679083 @default.
- W3037654920 creator A5049554771 @default.
- W3037654920 creator A5064393266 @default.
- W3037654920 date "2020-06-26" @default.
- W3037654920 modified "2023-09-25" @default.
- W3037654920 title "Tenapanor: new approach to counter irritable bowel syndrome with constipation" @default.
- W3037654920 doi "https://doi.org/10.18203/2319-2003.ijbcp20202961" @default.
- W3037654920 hasPublicationYear "2020" @default.
- W3037654920 type Work @default.
- W3037654920 sameAs 3037654920 @default.
- W3037654920 citedByCount "0" @default.
- W3037654920 crossrefType "journal-article" @default.
- W3037654920 hasAuthorship W3037654920A5009987567 @default.
- W3037654920 hasAuthorship W3037654920A5029679083 @default.
- W3037654920 hasAuthorship W3037654920A5049554771 @default.
- W3037654920 hasAuthorship W3037654920A5064393266 @default.
- W3037654920 hasBestOaLocation W30376549201 @default.
- W3037654920 hasConcept C126322002 @default.
- W3037654920 hasConcept C2775913212 @default.
- W3037654920 hasConcept C2776956441 @default.
- W3037654920 hasConcept C2778271842 @default.
- W3037654920 hasConcept C2779802037 @default.
- W3037654920 hasConcept C2780955771 @default.
- W3037654920 hasConcept C2781112942 @default.
- W3037654920 hasConcept C71924100 @default.
- W3037654920 hasConcept C90924648 @default.
- W3037654920 hasConceptScore W3037654920C126322002 @default.
- W3037654920 hasConceptScore W3037654920C2775913212 @default.
- W3037654920 hasConceptScore W3037654920C2776956441 @default.
- W3037654920 hasConceptScore W3037654920C2778271842 @default.
- W3037654920 hasConceptScore W3037654920C2779802037 @default.
- W3037654920 hasConceptScore W3037654920C2780955771 @default.
- W3037654920 hasConceptScore W3037654920C2781112942 @default.
- W3037654920 hasConceptScore W3037654920C71924100 @default.
- W3037654920 hasConceptScore W3037654920C90924648 @default.
- W3037654920 hasIssue "7" @default.
- W3037654920 hasLocation W30376549201 @default.
- W3037654920 hasOpenAccess W3037654920 @default.
- W3037654920 hasPrimaryLocation W30376549201 @default.
- W3037654920 hasRelatedWork W1465481857 @default.
- W3037654920 hasRelatedWork W1929619150 @default.
- W3037654920 hasRelatedWork W2045419223 @default.
- W3037654920 hasRelatedWork W2065849014 @default.
- W3037654920 hasRelatedWork W2086642698 @default.
- W3037654920 hasRelatedWork W2087874490 @default.
- W3037654920 hasRelatedWork W2098294301 @default.
- W3037654920 hasRelatedWork W2147533789 @default.
- W3037654920 hasRelatedWork W2397949841 @default.
- W3037654920 hasRelatedWork W3110664329 @default.
- W3037654920 hasVolume "9" @default.
- W3037654920 isParatext "false" @default.
- W3037654920 isRetracted "false" @default.
- W3037654920 magId "3037654920" @default.
- W3037654920 workType "article" @default.